Bradsaúde S.A. (BVMF:SAUD3)
| Market Cap | 45.84B +533.3% |
| Revenue (ttm) | 10.68B +328.1% |
| Net Income | 1.05B +81.7% |
| EPS | 1.19 +11.8% |
| Shares Out | 2.92B |
| PE Ratio | 13.16 |
| Forward PE | 9.47 |
| Dividend | 0.81 (5.19%) |
| Ex-Dividend Date | Sep 25, 2026 |
| Volume | 4,136,700 |
| Open | 15.15 |
| Previous Close | 15.06 |
| Day's Range | 15.15 - 15.68 |
| 52-Week Range | 10.39 - 16.57 |
| Beta | 0.57 |
| Analysts | Strong Buy |
| Price Target | 18.06 (+15.18%) |
| Earnings Date | Oct 21, 2026 |
About Bradsaúde
Bradsaúde S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of storage, loading, orga... [Read more]
Financial Performance
In 2025, Bradsaúde's revenue was 2.55 billion, an increase of 5.41% compared to the previous year's 2.41 billion. Earnings were 582.57 million, an increase of 8.03%.
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for SAUD3 stock is "Strong Buy." The 12-month stock price target is R$18.06, which is an increase of 15.18% from the latest price.
News
Bradsaúde Earnings Call Transcript: Q2 2026
Membership grew to 13.6 million with strong SME and dental additions, revenue rose 10.8% to BRL 13.9 billion, and net income increased 24.8% year-over-year. Atlântica Hospitais' net income quadrupled, and loss ratio remained stable at 83.3%.
Bradsaúde Earnings release: Q2 2026
Bradsaúde released its Q2 2026 earnings on August 4, 2026, summarizing the period's financial results.
Bradsaúde Slides: Q2 2026
Bradsaúde has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 4, 2026.
Bradsaúde Quarterly report: Q2 2026
Bradsaúde has published its Q2 2026 quarterly earnings report on August 4, 2026.
Bradsaúde Earnings Call Transcript: Q1 2026
First quarter 2026 saw 5% revenue growth, strong net margins, and robust membership gains, driven by SME and individual plans. Management remains cautious on claims ratios and medical inflation, while investing in hospital expansion and premium products to sustain long-term growth.
Bradsaúde Earnings release: Q1 2026
Bradsaúde released its Q1 2026 earnings on May 5, 2026, summarizing the period's financial results.
Bradsaúde Slides: Q1 2026
Bradsaúde has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 5, 2026.
Bradsaúde Quarterly report: Q1 2026
Bradsaúde has published its Q1 2026 quarterly earnings report on May 5, 2026.
Bradsaúde Earnings Call Transcript: Q4 2025
Reported 5.3% revenue growth and record new lives in 2025, led by SME segment expansion and improved cost efficiency. Integration into a broader health ecosystem marks a new growth phase, with a strong cash position and positive outlook for 2026.
Bradsaúde Earnings release: Q4 2025
Bradsaúde released its Q4 2025 earnings on February 26, 2026, summarizing the period's financial results.
Bradsaúde Slides: Q4 2025
Bradsaúde has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
Bradsaúde Annual report: Q4 2025
Bradsaúde has published its Q4 2025 annual report on February 26, 2026.
Bradsaúde Transcript: Status update
A leading dental plan provider with a technology-driven, asset-light model, strong bank partnerships, and nationwide reach, is expanding its high-margin SME segment while maintaining zero debt and distributing nearly all profits as dividends. Margins and efficiency are rising, with further growth potential in underpenetrated markets and continued focus on technology and shareholder returns.
Bradsaúde Earnings Call Transcript: Q3 2025
Net revenue and average ticket rose 7% year-over-year, with record SME growth and a 32% EBITDA margin. CapEx is trending down, and nearly BRL 1.3 billion was distributed to shareholders. SME and individual plans are driving portfolio transformation.
Bradsaúde Earnings release: Q3 2025
Bradsaúde released its Q3 2025 earnings on November 5, 2025, summarizing the period's financial results.
Bradsaúde Slides: Q3 2025
Bradsaúde has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 5, 2025.
Bradsaúde Quarterly report: Q3 2025
Bradsaúde has published its Q3 2025 quarterly earnings report on November 5, 2025.